Navigation Links
Prasco® Launches Authorized Generic of Shire's Carbatrol®
Date:1/12/2012

CINCINNATI, Jan. 12, 2012 /PRNewswire/ -- Prasco® Laboratories announced today it has entered into an agreement with Shire (NASDAQ: SHPGY) for the distribution in the U.S. of the Authorized Generic version of Carbatrol® (Carbamazepine) Extended-Release Capsules in 100 mg, 200 mg and 300 mg strengths.

Carbamazepine Extended-Release Capsules are AB-rated, therapeutically equivalent and substitutable for the brand Carbatrol®. The product will be distributed in the U.S. under the Prasco label. Financial terms of the agreement were not disclosed.

"We are pleased to provide Carbamazepine Extended-Release Capsules to pharmacists and consumers," said Prasco chief executive officer Christopher H. Arington. "As a Prasco Authorized Generic, Carbamazepine Extended-Release Capsules will provide patients with a therapeutically equivalent product to the brand."

Indications

Carbatrol is a medicine used to treat:

  • certain types of seizures (partial, tonic-clonic, mixed).
  • certain types of nerve pain (trigeminal and glossopharyngeal neuralgia).

Carbatrol is not a regular pain medicine and should not be used for aches or pains.

Important Safety Information

Do not stop taking Carbatrol without first talking to your doctor. Stopping Carbatrol suddenly can cause serious problems. Stopping seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus).

WARNING

SERIOUS SKIN REACTIONS

Carbatrol may cause rare but serious rashes that may lead to death. These serious skin reactions are more likely to happen within the first four months of Carbatrol treatment but may occur at later times
'/>"/>

SOURCE Prasco Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
2. Prasco® Launches Authorized Generic with Shionogi Inc.
3. Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
4. MX.com Launches Pelvic Health Program Model to Help Hospitals Rapidly Expand Key Services
5. Shopko Launches Mobile Pharmacy App to Maximize Customer Convenience
6. QIAGEN Launches QIAensemble Decapper Sample Preparation Automation System
7. Revation Systems Launches an Accessible Virtual Care Solution for Healthcare Organizations
8. Verenium Launches Second Enzyme Product for Oilfield Services
9. Successful Diabetes Product Launches Balance Digital & Traditional Public Relations Tools
10. Actavis Launches Generic Equivalent of Ritalin LA® in the US, With 180-Day Exclusivity
11. theVisualMD Launches a Revolutionary New Visual Path to Wellness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... MEETING, Pa. , Sept. 22, 2014 /PRNewswire/ ... announced today it has initiated a phase I ... trial will evaluate the safety, tolerability, and immunogenicity ... 6 (HPV-6), which causes most aerodigestive cancers. ... nose, throat, vocal cords, and parts of the ...
(Date:9/22/2014)... and NEW YORK , ... (OTCBB: ACCP), has signed an exclusive, global license ... development and commercialization of its proprietary plasma fractionation ... management team and its intention to strategically refocus ... and its plans to pursue a national listing ...
(Date:9/22/2014)... CHESTERBROOK, Pa. , Sept. 22, 2014 /PRNewswire/ ... ), a specialty biopharmaceutical company, today announced that ... the unsolicited, non-binding and conditional proposal from Endo ... independent financial and legal advisors, has unanimously determined ... terms of its existing merger agreement with QLT ...
Breaking Medicine Technology:Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6Auxilium Provides Transaction Update 2Auxilium Provides Transaction Update 3Auxilium Provides Transaction Update 4Auxilium Provides Transaction Update 5Auxilium Provides Transaction Update 6
... OAKBROOK TERRACE, Ill., Sept. 16 Pain is,just ... actually one of the main,reasons that Americans seek medical ... recovery times, poor quality of life and higher,health care ... campaign to help Americans,work with their health care professionals ...
... Expand NHL Marketplace with, Novel Antibody and Speedy ... COLUMBIA, Canada, Sept. 16 InNexus,Biotechnology Inc. (TSX ... a drug development company commercializing the next,generation of ... (DXL(TM)), announced today the results of an extensive ...
Cached Medicine Technology:Joint Commission Urges Patients to 'Speak Up' About Pain 2Joint Commission Urges Patients to 'Speak Up' About Pain 3InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies 2InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies 3
(Date:9/22/2014)... September 22, 2014 An inventor and ... to the problem of side-sleeping. "My lower arm always ... I designed a solution to this problem," she said. ... than to have your arm 'fall asleep.'" , The ... or her side more comfortably. It avoids pain and ...
(Date:9/22/2014)... 2014 Quincy Bioscience, one of ... promotes National Self-Improvement Month this September. ... should have access to self-improvement resources, especially for ... demand for products that preserve health is growing ... For over six years, Quincy Bioscience has been ...
(Date:9/22/2014)... The Workgroup for Electronic Data ... on the use of health IT to create ... its recent industry survey on the use of ... transactions adopted under the Health Insurance Portability and ... August 20 to September 5, which included 262 ...
(Date:9/22/2014)... new prescription devices approved by the U.S. Food and ... with migraine headaches who don,t tolerate migraine medications well, ... the Cefaly -- is designed to prevent migraines, while ... to be used when migraines first start, according to ... for alternative migraine treatments. Because these devices aren,t ingested ...
(Date:9/22/2014)... Pain does not need to rule your ... and reader-friendly book designed to guide the individual who suffers ... inspirational book is written to help the reader who is ... to regain a pain-free life — a daily “go-to” guide ... Chronic pain has become an epidemic, with over 100 million ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2
... surgeons offer tips on knowing when you,re ready to drive again ... the drive to get behind the wheel again after orthopedic surgery ... as simple as turning the key. , Orthopedic surgeons weigh in ... of Bone and Joint Surgery . , "Deciding when a ...
... Son Featured in TV and Radio Ads , ... Advertising Council, in partnership with Autism Speaks, announced today the ... featuring Grammy award-winning recording artist Toni Braxton and her son, ... parents to learn the early warning signs of this developmental ...
... Targeted Therapies to Achieve Better Efficacy and Toxicity Profiles Than ... , , WALTHAM, Mass., Dec. ... and advisory firms focusing on pharmaceutical and healthcare issues, forecasts ... from $35 million in 2007 to $64 million by 2012. ...
... Wisconsin Among States with Hurdles Ahead, According to New ... , NASHVILLE, Tenn., Dec. 10 HealthLeaders-InterStudy, ... that states will face pressure to re-examine their government-sponsored ... lose their jobs or come off severance packages and ...
... , RESEARCH TRIANGLE PARK, ... provider of drug development and manufacturing services to the ... of its new U.S. headquarters and analytical lab facilities ... Carolina. , Established nearly five decades ago ...
... Non-Cash Write-Down for MAPLE Asset and MDS Pharma Services, ... 10 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ ... life-sciences markets, today provided an update for fiscal 2008 performance. , ... fiscal 2008 net revenue in the range of $1,210 million to ...
Cached Medicine News:Health News:Returning to the Road Tricky After Injury 2Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 2Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 4Health News:India's Breast Cancer Drug Market Will Almost Double by 2012 2Health News:Economic Downturn Means Increased Demands on Budget-Challenged State Health Coverage Initiatives 2Health News:Economic Downturn Means Increased Demands on Budget-Challenged State Health Coverage Initiatives 3Health News:Patheon Opens New U.S. Headquarters and Analytical Laboratory Facility in Research Triangle Park, NC 2Health News:Patheon Opens New U.S. Headquarters and Analytical Laboratory Facility in Research Triangle Park, NC 3Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4
Knife rasp for shoulder arthroscopy....
Loop handle knot pusher...
Shoulder rasp...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
Medicine Products: